164 related articles for article (PubMed ID: 22139404)
1. Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.
Kodama M; Komura H; Kodama T; Nishio Y; Kimura T
Endocr J; 2012; 59(2):153-9. PubMed ID: 22139404
[TBL] [Abstract][Full Text] [Related]
2. The importance of estrogen replacement in young women with Turner syndrome.
Hanton L; Axelrod L; Bakalov V; Bondy CA
J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185
[TBL] [Abstract][Full Text] [Related]
3. A retrospective multicenter study of bone mineral density in adolescents and adults with Turner syndrome in Japan.
Itonaga T; Koga E; Nishigaki S; Kawai M; Sakakibara H; Hasegawa Y
Endocr J; 2020 Oct; 67(10):1023-1028. PubMed ID: 32554947
[TBL] [Abstract][Full Text] [Related]
4. Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome.
Nguyen HH; Wong P; Strauss BJ; Jones G; Ebeling PR; Milat F; Vincent A
Climacteric; 2017 Oct; 20(5):436-441. PubMed ID: 28523940
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and fractures in Turner syndrome.
Bakalov VK; Chen ML; Baron J; Hanton LB; Reynolds JC; Stratakis CA; Axelrod LE; Bondy CA
Am J Med; 2003 Sep; 115(4):259-64. PubMed ID: 12967689
[TBL] [Abstract][Full Text] [Related]
6. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome.
Cleemann L; Hjerrild BE; Lauridsen AL; Heickendorff L; Christiansen JS; Mosekilde L; Gravholt CH
Eur J Endocrinol; 2009 Aug; 161(2):251-7. PubMed ID: 19447901
[TBL] [Abstract][Full Text] [Related]
7. Starting age of oestrogen-progestin therapy is negatively associated with bone mineral density in young adults with Turner syndrome independent of age and body mass index.
Nishigaki S; Itonaga T; Hasegawa Y; Kawai M
Clin Endocrinol (Oxf); 2021 Jul; 95(1):84-91. PubMed ID: 33872421
[TBL] [Abstract][Full Text] [Related]
8. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the Rate of Increase of Estrogen Replacement Therapy on Bone Mineral Density Accrual in Young Patients with Turner Syndrome.
Brander EPA; Keenahan LA; Sangi-Haghpeykar H; Graham M; Dietrich JE
J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):353-357. PubMed ID: 36934800
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Long-Term Estrogen Replacement Therapy in Turner Syndrome Women with Premature Ovarian Insufficiency.
Son KA; Lee DY; Yoon BK; Choi D
J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):530-534. PubMed ID: 31145987
[TBL] [Abstract][Full Text] [Related]
11. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
12. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome.
Nakamura T; Tsuburai T; Tokinaga A; Nakajima I; Kitayama R; Imai Y; Nagata T; Yoshida H; Hirahara F; Sakakibara H
Endocr J; 2015; 62(11):965-70. PubMed ID: 26289838
[TBL] [Abstract][Full Text] [Related]
14. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys.
Jayo MJ; Register TC; Carlson CS
Bone; 1998 Oct; 23(4):361-6. PubMed ID: 9763148
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies.
Suganuma N; Furuhashi M; Hirooka T; Moriwaki T; Hasegawa Y; Mori O; Ogawa M
Endocr J; 2003 Jun; 50(3):263-9. PubMed ID: 12940454
[TBL] [Abstract][Full Text] [Related]
16. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
[TBL] [Abstract][Full Text] [Related]
17. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with the reduction of bone density in patients with gonadal dysgenesis.
Benetti-Pinto CL; Bedone A; Magna LA; Marques-Neto JF
Fertil Steril; 2002 Mar; 77(3):571-5. PubMed ID: 11872214
[TBL] [Abstract][Full Text] [Related]
19. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
[TBL] [Abstract][Full Text] [Related]
20. Fracture risk, underlying pathophysiology, and bone quality assessment in patients with Turner syndrome.
Ikegawa K; Hasegawa Y
Front Endocrinol (Lausanne); 2022; 13():967857. PubMed ID: 36325455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
